Adenosine A(2A) receptor enhances GABA(A)-mediated IPSCs in the rat globus pallidus - PubMed (original) (raw)

Adenosine A(2A) receptor enhances GABA(A)-mediated IPSCs in the rat globus pallidus

T Shindou et al. J Physiol. 2001.

Abstract

1. The actions of adenosine A(2A) receptor agonists were examined on GABAergic synaptic transmission in the globus pallidus (GP) in rat brain slices using whole-cell patch-clamp recording. GP neurones were characterized into two major groups, type I and type II, according to the degree of time-dependent hyperpolarization-activated inward rectification and the size of input resistance. 2. The A(2A) receptor agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido- adenosine (CGS21680; 0.3-3 microM) enhanced IPSCs evoked by stimulation within the GP. The actions of CGS21680 were blocked by the A(2A) antagonists (E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine (KF17837) and 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM241385). 3. The CGS21680-induced increase in IPSCs was associated with a reduction in paired-pulse facilitation. CGS21680 (0.3 microM) increased the frequency of miniature IPSCs (mIPSCs) without affecting mIPSC amplitude. These observations demonstrated that the enhancement of IPSCs in the GP was attributable to presynaptic, but not postsynaptic, A(2A) receptors. 4. The results suggest that A(2A) receptors in the GP serve to inhibit GP neuronal activity, thereby disinhibiting subthalamic nucleus neurone activity. Thus, the A(2A) receptor-mediated presynaptic regulation in the GP, together with the A(2A) receptor-mediated intrastriatal presynaptic control of GABAergic neurotransmission described previously, may play a crucial role in controlling the neuronal functions of basal ganglia. This A(2A) receptor-mediated presynaptic dual control in the striatopallidal pathway could also afford the mode of action of A(2A) antagonists for ameliorating the symptoms of Parkinson's disease in an animal model.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Visual and electrophysiological characterization of GP neurones

A, infrared photograph of a GP neurone in a rat slice preparation. B, micrograph of a biocytin-filled GP neurone that was visualized using histochemical procedures after being recorded in the whole-cell configuration. C, voltage responses and spontaneous discharges of type I neurone in the GP. Type I neurones showed little or slight sag during hyperpolarizing pulses (C1, average steady-state to peak sag ratio of 0.82 ± 0.03 in 8 neurones). Spontaneous action potentials fired at 9.6 Hz (C3). D, voltage responses and spontaneous discharges of type II neurone in the GP. Injection of a hyperpolarizing pulse produced a prominent sag in the membrane potential in type II neurones (D1, average steady-state to peak sag ratio of 0.66 ± 0.01 in 16 neurones, P < 0.005 vs. type I neurones by Wilcoxon's rank sum test). Both type of neurones fired regular spikes from hyperpolarized potentials (C2 and D2). Voltage, time and current calibrations in C1 also apply to C2, D1 and D2. Scale bars: A, 20 μm; B, 100 μm.

Figure 2

Figure 2. Evoked GABAergic postsynaptic currents in GP neurones

Evoked IPSCs were induced by focal stimulation within the GP in GP neurones in a solution containing antagonists for non-NMDA and NMDA receptors (10 μ

m

CNQX and 50 μ

m

APV). A, time course of the amplitude of evoked IPSCs during the application of GABAA receptor antagonist (10 μ

m

bicuculline) (left), and superimposed traces (right) of an average of consecutive evoked IPSCs (5 traces) before (control) and during application of bicuculline and after (wash), taken at the indicated time points. Bicuculline was applied to the superfusion medium for the period indicated by the bar. Membrane potential = 0 mV. B, reversal potentials of GABAergic IPSCs. It reversed polarity at -50 mV, close to the chloride equilibrium potential.

Figure 3

Figure 3. CGS21680-induced enhancement of evoked IPSCs in the GP

A, enhancement of evoked IPSCs by an adenosine A2A receptor agonist, CGS21680. Left, the time course of the amplitude of evoked IPSCs during the application of CGS21680 (1 μ

m

); right, superimposed traces of an average of consecutive evoked IPSCs (8 traces) before (control) and during application of CGS21680 (1 μ

m

), taken at the indicated time points. B, effect of the adenosine A2A receptor antagonist KF17837 (0.5 μ

m

) on the CGS21680-induced enhancement of evoked IPSCs. KF17837 was applied to the superfusion medium for the period indicated by the bar. Evoked IPSCs were recorded in the presence of CNQX (10 μ

m

) and APV (50 μ

m

) at a holding potential of 0 mV.

Figure 4

Figure 4. Summary of pharmacological characterization of the adenosine A2A receptor-mediated GABAergic synaptic transmission

Data are normalized as a percentage of control values. The error bars represent

s.e.m.

The numbers of cells examined are given in parentheses. *P < 0.05 vs. 0 μ

m

CGS21680 by Steel's test; †P < 0.05, ††P < 0.005 vs. 1 μ

m

CGS21680 by Wilcoxon's rank sum test.

Figure 5

Figure 5. Effects of CGS21680 on PPF

A, reduction of PPF by CGS21680. The upper traces show typical superimposed traces of an average of consecutive IPSCs (8 traces) evoked by paired stimulation (50 ms interval) before (control) and during application of CGS21680 (1 μ

m

). The lower traces are the same as those above, except that the amplitude of the first IPSC recorded in control conditions has been normalized to the first IPSC recorded during CGS21680 application. B, mean PPF ratios in 8 different neurones under control conditions and in the presence of CGS21680 (1 μ

m

). PPF is decreased in the presence of CGS21680. The error bars represent

s.e.m.

*P < 0.001 vs. control by paired t test.

Figure 6

Figure 6. Spontaneous miniature GABAergic IPSCs in GP neurones

Spontaneous mIPSCs were recorded in a solution containing CNQX (10 μ

m

), APV (50 μ

m

) and TTX (0.5 μm). A, a continuous trace showing time course of mIPSCs during application of GABAA receptor antagonist (10 μ

m

bicuculline). B, example traces with an expanded time scale from A, taken at the indicated time points. These mIPSCs were recorded at a holding potential of 0 mV.

Figure 7

Figure 7. Analysis of spontaneous miniature IPSCs in the GP neurones

The data are taken from the same neurone. A, two consecutive traces of mIPSCs before (control) and during application of CGS21680 (0.3 μ

m

). B, time course of the frequency of mIPSCs during application of CGS21680 (0.3 μ

m

). C, cumulative probability distribution of mIPSC amplitude (left) and inter-event interval (right) before (1255 events) and during application of CGS21680 (1802 events). CGS21680 had no effect on the amplitude distribution (P > 0.2, Kolmogorov-Smirnov test for control vs. CGS21680), but shifted the frequency distribution to shorter inter-event intervals (P < 0.001, Kolmogorov-Smirnov test for control vs. CGS21680). The frequencies and amplitudes (mean ±

s.d.

) of mIPSCs were 4.59 Hz and 38.75 ± 24.08 pA in control and 6.01 Hz and 37.72 ± 23.14 pA during CGS21680 application, respectively.

Figure 8

Figure 8. Summary graph of the experiments which tested the effect of CGS21680 on mIPSC frequency and amplitude

Pooled data of 9 neurones show that CGS21680 (0.3 μ

m

) increased the mean frequency without affecting the mean amplitude of mIPSCs. Mean frequency (formula image) and mean amplitude (□) of mIPSC were 7.4 ± 0.9 Hz and 29.76 ± 2.36 pA before (control) and 9.8 ± 1.4 Hz and 30.75 ± 2.39 pA during application of CGS21680, respectively. CGS21680 increased the frequency of mIPSCs by 130 ± 4 %. The error bars represent

s.e.m.

*P < 0.01 vs. control by paired t test.

Comment in

Similar articles

Cited by

References

    1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends in Neurosciences. 1989;12:366–375. - PubMed
    1. Augood SJ, Emson PC. Adenosine A2a receptor mRNA is expressed by enkephalin cells but not by somatostatin cells in rat striatum: a co-expression study. Molecular Brain Research. 1994;22:204–210. - PubMed
    1. Chergui K, Bouron A, Normand E, Mulle C. Functional GluR6 kainate receptors in the striatum: Indirect downregulation of synaptic transmission. Journal of Neuroscience. 2000;20:2175–2182. - PMC - PubMed
    1. Chesselet MF, Delfs JM. Basal ganglia and movement disorders: an update. Trends in Neurosciences. 1996;19:417–422. - PubMed
    1. Cooper AJ, Stanford IM. Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurones in vitro. Journal of Physiology. 2000;527:291–304. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources